Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Has Aldea Hit On A Sober Approach To Alcohol-Intoxication Therapy?

This article was originally published in The Pink Sheet Daily

Executive Summary

Acute alcohol intoxication is an unmet medical need that can be both lethal and a cost drain for the health care system, Aldea says. It plans to develop its lead candidate, an ALDH-2 activator, for the rare genetic disorder Fanconi anemia as well.

You may also be interested in...

Rusnano Teams With Domain Associates To Co-Fund Life Sciences Companies And Establish Pharma JV In Russia

Russian sovereign fund is co-investing with Domain in the VC’s portfolio life sciences companies, and the pair also will fund a manufacturing facility in Russia.

Titan Hopes To Tap Into Niche Drug Addiction Market With Six-Month Implant

Titan says compliance and abuse-resistance will hook payers on new long-acting formulations vs. low-cost generics.

Alcoholism Drugs Wanted: Uncle Sam Offers Industry A Hand in R&D

As awareness of the biology of addiction slowly begins to take hold among the general population, medications could wind up being the next best thing to a Higher Power in helping to keep alcoholics sober


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts